Rodney Schlosser to United States
This is a "connection" page, showing publications Rodney Schlosser has written about United States.
Connection Strength
0.555
-
Trends in complications of pediatric rhinosinusitis in the United States from 2006 to 2016. Int J Pediatr Otorhinolaryngol. 2020 Jan; 128:109695.
Score: 0.072
-
Depression-Specific Outcomes After Treatment of Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2016 Apr; 142(4):370-6.
Score: 0.056
-
Depression in chronic rhinosinusitis: A controlled cohort study. Am J Rhinol Allergy. 2016 Mar-Apr; 30(2):128-33.
Score: 0.056
-
Is sex an independent prognostic factor in esthesioneuroblastoma? Am J Rhinol Allergy. 2015 Sep-Oct; 29(5):369-72.
Score: 0.054
-
Changing trends in sinus and septal surgery, 2007 to 2009. Int Forum Allergy Rhinol. 2012 Sep-Oct; 2(5):357-61.
Score: 0.043
-
Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence? Am J Rhinol Allergy. 2012 Jan-Feb; 26(1):18-22.
Score: 0.042
-
Demographic Disparities in the Federal Drug Approval Process for Allergic Rhinitis Medications. Laryngoscope. 2023 Apr; 133(4):755-763.
Score: 0.021
-
Association of Frailty Status and Dietary Patterns in a Nationally Representative Sample of United States Adults with Olfactory Dysfunction. Nutrients. 2022 Mar 15; 14(6).
Score: 0.021
-
Racial and ethnic disparities in paranasal sinus malignancies. Int Forum Allergy Rhinol. 2021 11; 11(11):1557-1569.
Score: 0.020
-
Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health-sponsored workshop. Int Forum Allergy Rhinol. 2020 09; 10(9):1037-1042.
Score: 0.019
-
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop. J Allergy Clin Immunol Pract. 2020 05; 8(5):1532-1549.e1.
Score: 0.018
-
Olfactory cleft and sinus opacification differentially impact olfaction in chronic rhinosinusitis. Laryngoscope. 2020 10; 130(10):2311-2318.
Score: 0.018
-
Impact of chronic rhinosinusitis on sleep: a controlled clinical study. Int Forum Allergy Rhinol. 2019 01; 9(1):16-22.
Score: 0.017
-
Taste impairment in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2018 07; 8(7):783-789.
Score: 0.016
-
Understanding the relationship between olfactory-specific quality of life, objective olfactory loss, and patient factors in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017 07; 7(7):734-740.
Score: 0.015
-
Olfactory Neuroblastoma: Fate of the Neck--A Long-term Multicenter Retrospective Study. Otolaryngol Head Neck Surg. 2016 Feb; 154(2):383-9.
Score: 0.014
-
Effect of Continued Medical Therapy on Productivity Costs for Refractory Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2015 Nov; 141(11):969-73.
Score: 0.014
-
Productivity costs decrease after endoscopic sinus surgery for refractory chronic rhinosinusitis. Laryngoscope. 2016 Mar; 126(3):570-4.
Score: 0.014
-
Does comorbid obesity impact quality of life outcomes in patients undergoing endoscopic sinus surgery? Int Forum Allergy Rhinol. 2015 Dec; 5(12):1085-94.
Score: 0.013
-
Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope. 2015 Jan; 125(1):25-32.
Score: 0.013